Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.14

€3.14

-3.680%
-0.12
-3.680%
-
 
27.03.26 / Frankfurt WKN: A3CRZT / Name: Affluent Medical Sas / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Affluent Medical Sas Stock

Heavy losses for Affluent Medical Sas today as the stock fell by -€0.120 (-3.680%).

Pros and Cons of Affluent Medical Sas in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Carvolix joins key Euronext indices, marking a new milestone in its capital markets profile.
Carvolix joins key Euronext indices, marking a new milestone in its capital markets profile.
Carvolix joins key Euronext indices, marking a new milestone in its capital markets profile.
Carvolix : Estimated full-year 2025 results.
Carvolix : Estimated full-year 2025 results.
Carvolix : Estimated full-year 2025 results.
Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies.
Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies.
Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies.